2108 Reports20and20Data20logo 99

The global transcatheter pulmonary valve therapy market was valued at USD 37.8 million in 2018 and is expected to reach USD 66.4 million by the year 2026, at a CAGR of 7.2 percent. Transcatheter Pulmonary Valve Therapy has come up as the treatment of choice in most congenital heart disease patients with degeneration of a previous right ventricular outflow tract repair. To avoid the need for repeat median sternotomy procedures, less invasive catheter-based interventions to treat pulmonary valve dysfunction have been developed over time.

The global market is driven by the rising incidence of congenital heart diseases and increasing awareness associated with TPV Therapy. For instance, in the United States, the incidence of congenital heart defects ranges between 4 to10 cases per 1,000, clustering around 8 cases per 1,000 live births. Continental variations in birth prevalence have been observed, from about 6.9 cases per 1000 births in Europe to 9.3 cases per 1000 births in Asia. However, the relationship between valve size and balloon waist may reflect selection and procedural bias, which is likely to hinder the market growth

Top Companies Profiled in the Report Include:

 Medtronic, Edward Lifesciences, Cryolife Inc, and Venus Medtech.

Get a sample of the report @ URL https://www.reportsanddata.com/sample-enquiry-form/1067

Market Overview:

The pharma and healthcare industry has undergone a revolutionary change owing to the COVID-19 pandemic with individuals increasing their focus on health and wellness. Companies operating in the industry have invested heavily in clinical trials and research studies to develop medications to cater to the growing unmet clinical demand on a global level. Implementation of cutting-edge technology in healthcare sector and increasing investment in research and development have contributed significantly to revenue growth of the market in the recent past. In addition, availability of favorable health insurance and reimbursement policies have also positively impacted the healthcare sector with more and more individuals opting to get treatment at hospital and clinical facilities. Rapid development of novel drugs and pharmaceuticals, increasing incidence of lifestyle and chronic diseases, establishment of state-of-the-art healthcare facilities, and rising availability of over-the-counter medications have significantly contributed to the revenue growth of the market.  

Request a discount on the report @ URL https://www.reportsanddata.com/discount-enquiry-form/1067

The report has gather vital information about recent mergers and acquisitions, joint ventures, collaborations, partnerships, brand promotions, R&D activities, and government and corporate deals, among others through extensive primary and secondary research. The report also offers detailed analysis of each competitor along with their financial standing, global market position, product portfolio, manufacturing and production capacity, and business expansion plans.

To know more about the report @ URL https://www.reportsanddata.com/press-release/global-transcatheter-pulmonary-valves-tpv-therapy-market

Additionally, the report consists a detailed analysis of the segmentation of the Transcatheter Pulmonary Valve (TPV) Therapy market based on product types and end-use/application offered in the Transcatheter Pulmonary Valve (TPV) Therapy market.

Type (Revenue, USD Million; 2016–2026)

Balloon expanded

Self-expanded Transcatheter Valve

Application Outlook (Revenue, USD Million; 2016–2026)


Cardiology Centers


The report offers a comprehensive overview of the regional bifurcation of the market with respect to market share, market size, revenue growth, import/export, production and consumption patterns, macro and micro economic growth factors, regulatory framework, investment and funding opportunities, and presence of key players in each region including North America, Asia Pacific, Latin America, Europe, and Middle East & Africa. The report offers a country-wise analysis to further discuss the revenue growth and lucrative growth opportunities for the Transcatheter Pulmonary Valve (TPV) Therapy market in these key regions.

Country-wise regional analysis covers:

North America


Asia Pacific

Latin America

Middle East & Africa

Thank you for reading our report. For customization inquiry or further information, please connect with us and we will ensure you get the report that meets your requirements.  

 Read More Reports

Neuroscience Antibodies and Assays Market @ https://www.biospace.com/article/neuroscience-antibodies-and-assays-market-size-to-reach-usd-7-06-billion-in-2028-says-reports-and-data-/

Clinical Microbiology Market @ https://www.biospace.com/article/clinical-microbiology-market-size-to-reach-usd-6-6-billion-in-2028-noted-reports-and-data/

Biostimulants Market @ https://www.biospace.com/article/biostimulants-market-size-to-reach-usd-6-75-billion-in-2028-says-reports-and-data/

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.                    

Tags: Transcatheter Pulmonary Valve (TPV) Therapy Market 2021,  , Asia-Pacific Transcatheter Pulmonary Valve (TPV) Therapy Market, Transcatheter Pulmonary Valve (TPV) Therapy Market Drivers, Transcatheter Pulmonary Valve (TPV) Therapy Market Distribution Channel

See Campaign: https://www.reportsanddata.com/press-release/global-transcatheter-pulmonary-valves-tpv-therapy-marke
Contact Information:
John Watson Head of Business Development Direct Line: +1-212-710-1370 E-mail: sales@reportsanddata.com Reports and Data | Web: www.reportsanddata.com

PR-Wirein, Menafn, Reportedtimes, iCN Internal Distribution, Research Newswire, English